QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Study Promising Candidate in Phase 2 GBM Trial
CNS Pharmaceuticals (NASDAQ: CNSP) is on track to begin a potentially pivotal Phase 2 trial during the second quarter of…
CNS Pharmaceuticals (NASDAQ: CNSP) is on track to begin a potentially pivotal Phase 2 trial during the second quarter of…
The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER), the largest independent alkaline water company in the United States, today announced…
Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, recently…
Imagin Medical (CSE: IME) (OTCQB: IMEXF), a surgical imaging company, is looking to change how cystoscopies for bladder cancer are…
BAND Royalty today announced its placement in an editorial published by NetworkNewsWire ("NNW"), one of 50+ trusted brands within the…
Vivos Therapeutics (NASDAQ: VVOS) founder and chief medical officer, Dr. G. Dave Singh, DMD, PhD, DDSc, has written a new…
VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company committed to developing a new generation of medicines with the potential to go…
Golden Triangle Ventures (OTC: GTVH) (“GTV”) today announced the acquisition of The Lodge Winery & Olive Oil Co. under GTV’s…
Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, today announced that it has filed an…
Excellon Resources (TSX: EXN) (NYSE American: EXN) (FSE: E4X2) today announced the commencement of a 2,800-metre diamond drilling program at…